• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LYRA

LYRA

Lyra Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.44

-0.06 (-11.98%)

Company Profile

CEO

Carmichael S. Roberts Jr.

IPO Date

2020-05-01

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.46

Prev. Close

$0.50

Day Low

$0.44

Day High

$0.48

52W Low

$0.44

52W High

$37.50

Market Cap

$0.00B

Volume

0.08M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

45.2%

Avg Negative

10.3%

Avg Neutral

44.7%

News Feed

Lyra Therapeutics to Present at Upcoming Virtual Healthcare Conference

GlobeNewsWire·7/12/2021·↑ positive

Lyra Therapeutics Announces Positive Topline Results of Pharmacokinetic Study of LYR-210 in Patients with Chronic Rhinosinusitis

GlobeNewsWire·6/30/2021·↑ positive

Lyra Therapeutics Stock Is Trading Higher After Positive FDA Meeting Outcome For Rhinosinusitis Program

Benzinga·6/9/2021·↑ positive

Lyra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for LYR-210 for the Treatment of Chronic Rhinosinusitis

Business Wire·6/8/2021·↑ positive

Lyra Therapeutics, Inc. (LYRA) CEO Maria Palasis on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/11/2021·↓ negative

Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual

Business Wire·4/11/2021·↑ positive

Lyra Therapeutics, Inc. (LYRA) CEO Maria Palasis on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/9/2021·↓ negative

Why Earnings Season Could Be Great for Lyra Therapeutics (LYRA)

Zacks Investment Research·3/1/2021·↑ positive

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Lyra Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire·1/15/2021·↓ negative

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Lyra Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire·1/13/2021·↓ negative